Radiosensitizing, toxicological, and pharmacokinetic properties of hydroxamate analogues of nitroimidazoles as bifunctional radiosensitizers/chemical modifiers-Reference-Cited by-同舟云学术

Radiosensitizing, toxicological, and pharmacokinetic properties of hydroxamate analogues of nitroimidazoles as bifunctional radiosensitizers/chemical modifiers

Published:1992-01 Issue:3 Volume:22 Page:561-564
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Nagasawa Hideko,Bando Masahiro,Hori Hitoshi,Satoh Tetsuo,Tada Takuhito,Onoyama Yasuto,Inayama Seiichi

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference7 articles.

1. Analogues of RSU-1069:Radiosensitization and toxicity in vitro and in vivo;Ahmed;Int. J. Radiat. Oncol. Biol. Phys.,1986

2. Partition coefficient as a guide to the development of radiosensitizers which are less toxic than misonidazole;Brown;Radiat. Res.,1980

3. SR-2508: A 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use;Brown;Int. J. Radiat. Oncol. Biol. Phys.,1982

4. A new substituent constant, π derived from partition coefficients;Fujita;J. Am. Chem. Soc.,1964

5. KIH-802: 2-nitroimidazole-I-acetohydroxamate as a hypoxic cell radiosensitizer;Hori;Int. J. Radiat. Oncol. Biol. Phys.,1989

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nitroimidazole Radiopharmaceuticals in Hypoxia: Part II Cytotoxicity and Radiosensitization Applications;Current Radiopharmaceuticalse;2011-10-01

2. The novel hypoxic cell radiosensitizer, TX-1877 has antitumor activity through suppression of angiogenesis and inhibits liver metastasis on xenograft model of pancreatic cancer;Cancer Letters;2008-12

3. Design, synthesis, and radiosensitizing activities of sugar-hybrid hypoxic cell radiosensitizers;Bioorganic & Medicinal Chemistry;2008-01

4. TX-1877, a bifunctional hypoxic cell radiosensitizer, enhances anticancer host response: Immune cell migration and nitric oxide production;International Journal of Cancer;2005

5. A novel hypoxia-dependent 2-nitroimidazole KIN-841 inhibits tumour-specific angiogenesis by blocking production of angiogenic factors;British Journal of Cancer;2003-01